# Non-alcoholic Steatohepatitis Registry Platform Study

> **NCT06123858** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 1122 (actual)

## Conditions studied

- NASH With Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06123858
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-11-22
- **Primary completion:** 2025-10-17
- **Final completion:** 2025-10-17
- **Target enrollment:** 1122 (ACTUAL)
- **Why stopped:** Following a reassessment of the company's pipeline priorities, the sponsor has elected to discontinue this project prior to its planned completion
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06123858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06123858, "Non-alcoholic Steatohepatitis Registry Platform Study". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06123858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*